Evaluating Elbow Flexion After Free Functional Gracilis Muscle Transfer in Adult Brachial Plexus Lnjury
1 other identifier
interventional
22
1 country
1
Brief Summary
- Study Overview This single-arm prospective clinical trial evaluates the efficacy of gracilis free functional muscle transfer (FFMT) for restoring elbow flexion in patients with late-presenting brachial plexus injuries (≥12 months post-injury) or failed prior reconstructive surgery. The gracilis muscle is the preferred donor due to its reliable vascular pedicle, adequate excursion, long motor nerve, and minimal donor-site morbidity .
- Primary Objective To assess postoperative elbow flexion strength using the British Medical Research Council (BMRC) grading system following gracilis FFMT neurotized by intercostal nerves (ICN) or spinal accessory nerve (SAN).
- Secondary Objectives
- Evaluate active range of motion (AROM)
- Measure time to first detectable muscle contraction and time to maximum power
- Assess functional improvement via DASH scores
- Compare outcomes between ICN and SAN neurotization groups
- Compare outcomes between pediatric and adult patients
- Document complications, particularly elbow flexion contracture
- Key Inclusion Criteria
- Age 4-50 years
- Elbow flexion loss or severe weakness for \>12 months following brachial plexus injury (obstetric or traumatic)
- Weak ipsilateral latissimus dorsi and pectoralis major (\<M3), unsuitable for local muscle transfer
- Key Exclusion Criteria
- Age \<4 years (microvascular anastomosis feasibility concerns)
- Age \>50 years (diminished regenerative capacity)
- Presentation within 12 months of injury
- Reconstructable by local muscle or nerve transfer
- Elbow joint stiffness or contracture
- Uncontrolled comorbidities or inability to comply with rehabilitation
- Intervention Gracilis FFMT harvested from the contralateral thigh with:
- \*\*Neurotization:\*\* ICNs (50%) or SAN (50%)
- \*\*Vascular anastomosis:\*\* Thoracoacromial artery (77%), thoracodorsal artery (13.6%), or subscapular artery (9.2%)
- \*\*Muscle tensioning:\*\* Elbow flexed 90-110° during inset
- Primary Outcome Measure Postoperative elbow flexion power (BMRC grade) at 24-month follow-up
- Secondary Outcome Measures
- Active range of motion (goniometry)
- Time to first clinical contraction
- Time to maximum power achievement
- DASH score
- Complication rate (flap loss, flexion contracture, scarring)
- Sample Size 22 patients (17 male, 5 female; mean age 13.4±8.7 years)
- Statistical Considerations
- Paired t-test for continuous outcomes
- Wilcoxon signed-rank test for non-parametric data
- Fisher's exact test for categorical comparisons
- Significance threshold: p\<0.05
- Expected Outcomes Based on existing literature, 68-76% of patients achieve functionally useful elbow flexion (≥M3) following gracilis FFMT, with significant improvements in AROM and DASH scores . ICN neurotization may offer faster recovery to maximum power (approximately 9 months vs. 14 months for SAN) without compromising final strength .
- Trial Registration:\*\* Not reported (retrospective/prospective case series design)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2026
CompletedFirst Submitted
Initial submission to the registry
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 6, 2026
CompletedAugust 6, 2026
August 1, 2026
1 year
August 1, 2026
August 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
British Medical Research Council (BMRC) muscle power
elbow flexion power using the British Medical Research Council (BMRC)
18 months
Secondary Outcomes (3)
active and passive range of motion degree
18 months
first detectable clinical sign of muscle contraction
18 months
time to achieve its maximum possible power following rehabilitation
18 months
Study Arms (2)
Spinal acessory nerve neurotisation
EXPERIMENTALnecrotizing the free Gracilis by spinal accessory nerve
Intercostal nerve group
EXPERIMENTALnecrotizing the free Gracilis by 3 intercostal nerve
Interventions
neurotizing free Gracilis muscle by Spinal accessory nerve
neurotizing free Gracilis muscle by 3 intercostal nerves
Eligibility Criteria
You may qualify if:
- More than 12 months after injury
You may not qualify if:
- younger than 4 years
- older than 50
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aswan Universitylead
Study Sites (1)
Aswan University Hospitals
Aswān, Aswan Governorate, 32337, Egypt
Related Publications (1)
Armangil M, Unsal SS, Yildirim T, Bezirgan U, Keremov A, Adiyaman S, Bilgin SS. Outcome of free gracilis muscle transfer for the restoration of elbow flexion in traumatic brachial plexus palsy. Jt Dis Relat Surg. 2021;32(3):633-641. doi: 10.52312/jdrs.2021.225. Epub 2021 Nov 19.
PMID: 34842095RESULT
Related Links
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of plastic surgery
Study Record Dates
First Submitted
August 1, 2026
First Posted
August 6, 2026
Study Start
January 15, 2024
Primary Completion
January 15, 2025
Study Completion
May 15, 2026
Last Updated
August 6, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share